Fideuram Intesa Sanpaolo Private Banking S.P.A. Trims Stock Holdings in Cigna Group $CI

Fideuram Intesa Sanpaolo Private Banking S.P.A. lowered its stake in Cigna Group (NYSE:CI) by 21.6% during the first quarter, HoldingsChannel reports. The institutional investor owned 9,411 shares of the health services provider’s stock after selling 2,594 shares during the quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A.’s holdings in Cigna Group were worth $2,510,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Banco Bilbao Vizcaya Argentaria S.A. raised its holdings in shares of Cigna Group by 13.5% in the 3rd quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 34,114 shares of the health services provider’s stock valued at $9,839,000 after buying an additional 4,066 shares during the period. Distillate Capital Partners LLC boosted its holdings in Cigna Group by 19.1% during the 3rd quarter. Distillate Capital Partners LLC now owns 108,676 shares of the health services provider’s stock valued at $31,338,000 after acquiring an additional 17,442 shares during the period. Cooperman Leon G grew its position in Cigna Group by 53.3% in the 3rd quarter. Cooperman Leon G now owns 325,000 shares of the health services provider’s stock valued at $93,681,000 after acquiring an additional 113,000 shares in the last quarter. apricus wealth LLC increased its stake in Cigna Group by 715.9% during the fourth quarter. apricus wealth LLC now owns 9,505 shares of the health services provider’s stock worth $2,616,000 after purchasing an additional 8,340 shares during the period. Finally, Schroder Investment Management Group increased its stake in Cigna Group by 53.0% during the third quarter. Schroder Investment Management Group now owns 190,710 shares of the health services provider’s stock worth $54,972,000 after purchasing an additional 66,090 shares during the period. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Performance

Shares of Cigna Group stock opened at $287.50 on Friday. The business has a 50-day simple moving average of $285.09 and a 200-day simple moving average of $279.24. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. Cigna Group has a one year low of $239.51 and a one year high of $323.10. The company has a market cap of $76.05 billion, a PE ratio of 12.19, a P/E/G ratio of 1.11 and a beta of 0.29.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, beating the consensus estimate of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm had revenue of $68.52 billion for the quarter, compared to analysts’ expectations of $66.29 billion. During the same quarter last year, the company earned $6.74 earnings per share. The firm’s revenue was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, equities research analysts forecast that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th were issued a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date was Thursday, June 4th. Cigna Group’s dividend payout ratio (DPR) is presently 26.45%.

Insiders Place Their Bets

In other news, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the sale, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. The trade was a 27.52% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO David Cordani sold 201,878 shares of the business’s stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the transaction, the chief executive officer owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. The trade was a 85.46% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several research analysts have recently commented on CI shares. Morgan Stanley raised their price objective on shares of Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a research note on Wednesday, May 20th. Sanford C. Bernstein upped their target price on shares of Cigna Group from $358.00 to $371.00 and gave the stock an “outperform” rating in a research note on Tuesday, May 5th. Guggenheim increased their target price on shares of Cigna Group from $334.00 to $338.00 and gave the stock a “buy” rating in a report on Monday, May 4th. Cantor Fitzgerald raised their price target on shares of Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a research report on Friday, May 1st. Finally, The Goldman Sachs Group boosted their price target on shares of Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $338.30.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.